Fifth Icon Cancer Centre opens in China

Icon Writers / 26 4月, 2022

Icon's fifth China centre opens in the Henan province

This month, April 2022, Icon Group’s fifth cancer centre in China commenced clinical operation. The centre was built in partnership with Sinohydro Bureau 11 Co. Ltd and is located on their Huanghe Sanmenxia Hospital campus.

Sanmenxia is in Henan province, China’s most populous province, and Icon’s new centre is situated within a growing hub that services the Henan, Shaanxi and Shanxi, the Yellow River Golden Triangle, communities. Alongside the full-service hospital, it will help contribute towards the China government’s ‘Health Sanmenxia 2030’ strategy to increase healthcare in the region and bring advanced technology and medical expertise to the community.

Cancer rates across China continue to increase, with high levels of cancer diagnosis across the Henan province but there is currently a lack of expertise and resources to meet the cancer burden. As with all Icon sites across China, this centre has been able to see reality thanks to the collaborative effort of the group’s international team, in particular the Strategic Investment and Clinical Care team. This experienced multidisciplinary team work closely with Icon’s teams in China to deliver innovative remote radiation therapy functions, including patient planning and clinical training utilising assisted reality headsets to ensure the site meets a consistent standard of care and elevates local radiation therapy clinical expertise.

The centre is equipped with a Varian TrueBeam linear accelerator which has the capacity to deliver HyperArc – the latest in precision radiation therapy for multiple brain metastases. This new site builds upon Icon’s growing network of cancer centres in China at Jiangxian, Chongqing, Qingdao and Fengcheng.

查看所有 新聞

由於內容尚未被翻譯成中文,您將會被轉到英文頁面。

搜尋

聯絡我們